2021 Collaborative Group of the Americas (CGA) Annual Meeting

2021 Collaborative Group of the Americas (CGA) Annual Meeting is organized by Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) and will be held from Nov 13 - 15, 2021 at Loews Vanderbilt Hotel, Nashville, Tennessee, United States of America.

Who Should Attend:
The 2021 CGA Annual Meeting will be directed to colorectal surgeons, medical oncologists, gastroenterologists, internists, gynecologists,  researchers, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other professionals involved in the care of individuals with hereditary gastrointestinal cancer, including colorectal, esophageal, pancreatic, gastric, and small bowel cancers.

Description:
The CGA Annual Meeting will provide critical data and information designed to keep clinicians and scientists up-to-date on new developments in hereditary gastrointestinal cancer research, including implications for physicians, psychologists, nurses, and genetic counselors to make informed decisions about the prevention, diagnosis, and treatment of patients with hereditary gastrointestinal cancer syndromes.

Objectives Topics
After completing this activity, participants will be able to do the following:
• Summarize recent research on the basic biology of gastrointestinal cancer development, including modifiers of the hereditary phenotypes
• Describe potential implications for clinical practice
• Implement new approaches to screening and preventing gastrointestinal cancers
• Summarize the evidence for new diagnostics, devices, and pharmaceuticals
• Describe the impact of newly discovered genes and the use of recently introduced gene panels to diagnose and manage hereditary gastrointestinal cancer syndromes
• Institute use of clinical and genetic modifiers of the hereditary cancer risk in their clinical practice 
• Define the changing care models for diagnosis and management of various hereditary cancer syndromes
• List the surgical approaches to hereditary gastrointestinal cancer syndromes for both treatment and prophylaxis 
• Describe patient criteria for referral for surgery that offers optimal outcomes

Additional details will be posted as soon as information is available.